Minor Issues: [4] In Figures 3G and 3H, please specify p-values for untreated vs selumetinib in FLO-1/EV and OE33/shMACC1 respectively.
[6] In line 306/307, please explain/speculate briefly why the control clone had higher MACC1 expression than the wildtype.